Adrie van Bokhoven, PhD The PCA3 assay could be particularly useful in finding prostate cancer sooner in African Americans. DENVER – The PCA3 urine test may improve early detection of prostate cancer, ...
May 12, 2008 — The urine test for the PCA3 gene, already marketed for use in diagnosing prostate cancer, could also be useful in prognostication. It might have clinical application in selecting men ...
In 1999, DD3 (differential display code 3) [now referred to as the PCA3 gene], a non-coding mRNA located on chromosome 9q21-22 with unknown function, was identified as being highly overexpressed ...
Test aims to help clinicians decide whether patients who test negative will need further biopsy procedures. FDA approved Gen-Probe’s Progensa® PCA3 (Prostate Cancer gene 3) assay, which the firm ...
WASHINGTON (Reuters) - A urine test can help doctors better spot prostate cancer than either the current blood test or a rectal exam alone, U.S. researchers reported on Tuesday. They said Gen-Probe's ...
Add Yahoo as a preferred source to see more of our stories on Google. Researchers say they've developed a urine test that could answer whether prostate cancer is aggressive and requiring immediate ...
Randomized Controlled Trial of a Telephone-Based Peer-Support Program for Women Carrying a BRCA1 or BRCA2 Mutation: Impact on Psychological Distress Although all authors completed the disclosure ...
To date, men undergoing screening through the measurement of prostate-specific antigen (PSA) levels have had a significant reduction in neoplastic mortality. Because of its low specificity, however, ...
To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...
WASHINGTON, June 1 (Reuters) - A urine test can help doctors better spot prostate cancer than either the current blood test or a rectal exam alone, U.S. researchers reported on Tuesday. They said ...
When prostate cancer strikes, one question is paramount: Is it aggressive and requiring immediate treatment, or slow-growing and worthy of monitoring only? Right now, an invasive biopsy is the only ...